Loading...

Richard Garfein

TitleProfessor In Residence
InstitutionUniversity of California San Diego
DepartmentFamily Medicine and Public Health
Address9500 Gilman Drive #0507
La Jolla CA 92093
Phone858-822-3018
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California Santa Barbara, Santa Barbara, CABA1985Biology
    San Diego State University, School of Public Health, San Diego, CAMPH1989Epidemiology
    Johns Hopkins University, School of Hygiene and Public Health, Baltimore, MDPhD1997Infectious Diease Epidemiology

    Collapse Research 
    Collapse Research Activities and Funding
    Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment
    NIH/NIAID U01AI116392Mar 16, 2015 - Feb 28, 2020
    Role: Principal Investigator
    Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
    NIH/NIDA R01DA031074Aug 1, 2011 - May 31, 2016
    Role: Principal Investigator
    Mobile Phone-Based Video Directly Observed Therapy for Tuberculosis
    NIH/NIAID R21AI088326Apr 1, 2010 - Mar 31, 2013
    Role: Principal Investigator
    Cross-Border Dynamics of MDR/XDR-TB Epidemiology by HIV Status in Tijuana, Mexico
    NIH/NIAID R56AI081321Sep 27, 2009 - Aug 31, 2011
    Role: Principal Investigator
    Reducing Sexual HIV Risk among Methamphetamine-Using MSM in San Diego, CA
    CDC/NCHHSTP UR6PS000306Sep 30, 2006 - Sep 29, 2009
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Guise A, Melo J, Mittal ML, Rafful C, Cuevas-Mota J, Davidson P, Garfein R, Werb D. A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA. Int J Drug Policy. 2018 Mar 07; 55:51-60. PMID: 29524733.
      View in: PubMed
    2. Groessl EJ, Ganiats TG, Hillery N, Trollip A, Jackson RL, Catanzaro DG, Rodwell TC, Garfein R, Rodrigues C, Crudu V, Victor TC, Catanzaro A. Cost analysis of rapid diagnostics for drug-resistant tuberculosis. BMC Infect Dis. 2018 03 02; 18(1):102. PMID: 29499645.
      View in: PubMed
    3. Moor MA, Fraga MA, Garfein R, Rashidi HH, Alcaraz J, Kritz-Silverstein D, Elder JP, Brodine SK. Individual and community factors contributing to anemia among women in rural Baja California, Mexico. PLoS One. 2017; 12(11):e0188590. PMID: 29176817.
      View in: PubMed
    4. Roth AM, Felsher M, Reed M, Goldshear JL, Truong Q, Garfein R, Simmons J. Potential benefits of using ecological momentary assessment to study high-risk polydrug use. Mhealth. 2017; 3:46. PMID: 29184898.
      View in: PubMed
    5. Mittal ML, Vashishtha D, Sun S, Jain S, Cuevas-Mota J, Garfein R, Strathdee SA, Werb D. History of medication-assisted treatment and its association with initiating others into injection drug use in San Diego, CA. Subst Abuse Treat Prev Policy. 2017 Oct 03; 12(1):42. PMID: 28974239.
      View in: PubMed
    6. Seifert M, Georghiou SB, Garfein R, Catanzaro D, Rodwell TC. Impact of Fluoroquinolone Use on Mortality Among a Cohort of Patients With Suspected Drug-Resistant Tuberculosis. Clin Infect Dis. 2017 Sep 01; 65(5):772-778. PMID: 28475735.
      View in: PubMed
    7. Collier MG, Garfein R, Cuevas-Mota J, Teshale EH. Comparison of Three Popular Methods for Recruiting Young Persons Who Inject Drugs for Interventional Studies. J Urban Health. 2017 Aug; 94(4):587-591. PMID: 28488087.
      View in: PubMed
    8. Horyniak D, Wagner KD, Armenta RF, Cuevas-Mota J, Hendrickson E, Garfein R. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California. Int J Drug Policy. 2017 Sep; 47:9-17. PMID: 28683432.
      View in: PubMed
    9. Roth AM, Armenta RF, Wagner KD, Strathdee SA, Goldshear JL, Cuevas-Mota J, Garfein R. Cold Preparation of Heroin in a Black Tar Market. Subst Use Misuse. 2017 07 29; 52(9):1202-1206. PMID: 28605301.
      View in: PubMed
    10. Georghiou SB, Seifert M, Catanzaro DG, Garfein R, Rodwell TC. Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs. J Clin Microbiol. 2017 Jun; 55(6):1928-1937. PMID: 28404672.
      View in: PubMed
    11. Catanzaro DG, Trollip AP, Seifert M, Georghiou SB, Garfein R, Rodwell TC, Catanzaro A, Eisenach KD. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis. Eur Respir J. 2017 Apr; 49(4). PMID: 28381434.
      View in: PubMed
    12. Roth AM, Rossi J, Goldshear JL, Truong Q, Armenta RF, Lankenau SE, Garfein R, Simmons J. Potential Risks of Ecological Momentary Assessment Among Persons Who Inject Drugs. Subst Use Misuse. 2017 06 07; 52(7):840-847. PMID: 28426353.
      View in: PubMed
    13. Wood EF, Werb D, Beletsky L, Rangel G, Cuevas Mota J, Garfein R, Strathdee SA, Wagner KD. Differential experiences of Mexican policing by people who inject drugs residing in Tijuana and San Diego. Int J Drug Policy. 2017 03; 41:132-139. PMID: 28111221.
      View in: PubMed
    14. Pines HA, Wertheim JO, Liu L, Garfein R, Little SJ, Karris MY. Concurrency and HIV transmission network characteristics among MSM with recent HIV infection. AIDS. 2016 Nov 28; 30(18):2875-2883. PMID: 27662550.
      View in: PubMed
    15. Bojorquez I, Salazar I, Garfein R, Cerecer P, Rodwell TC. Surveillance or support: The experience of direct observation during tuberculosis treatment. Glob Public Health. 2016 Oct 16; 1-15. PMID: 27748157.
      View in: PubMed
    16. Werb D, Garfein R, Kerr T, Davidson P, Roux P, Jauffret-Roustide M, Auriacombe M, Small W, Strathdee SA. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J. 2016 09 15; 13(1):25. PMID: 27629248.
      View in: PubMed
    17. Meacham MC, Strathdee SA, Rangel G, Armenta RF, Gaines TL, Garfein R. Prevalence and Correlates of Heroin-Methamphetamine Co-Injection Among Persons Who Inject Drugs in San Diego, California, and Tijuana, Baja California, Mexico. J Stud Alcohol Drugs. 2016 Sep; 77(5):774-81. PMID: 27588536; PMCID: PMC5015469 [Available on 09/01/17].
    18. Georghiou SB, Seifert M, Lin SY, Catanzaro D, Garfein R, Jackson RL, Crudu V, Rodrigues C, Victor TC, Catanzaro A, Rodwell TC. Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis. BMC Infect Dis. 2016 08 31; 16:458. PMID: 27576542; PMCID: PMC5006534.
    19. Moor MA, Fraga MA, Garfein R, Harbertson J, Rodriguez-Lainz A, Rashidi HH, Elder JP, Brodine SK. Decreased Anemia Prevalence Among Women and Children in Rural Baja California, Mexico: A 6-Year Comparative Study. J Community Health. 2016 Aug; 41(4):780-9. PMID: 26856732.
      View in: PubMed
    20. Falzon D, Timimi H, Kurosinski P, Migliori GB, Van Gemert W, Denkinger C, Isaacs C, Story A, Garfein R, do Valle Bastos LG, Yassin MA, Rusovich V, Skrahina A, Van Hoi L, Broger T, Abubakar I, Hayward A, Thomas BV, Temesgen Z, Quraishi S, von Delft D, Jaramillo E, Weyer K, Raviglione MC. Digital health for the End TB Strategy: developing priority products and making them work. Eur Respir J. 2016 07; 48(1):29-45. PMID: 27230443.
      View in: PubMed
    21. Collins KM, Armenta RF, Cuevas-Mota J, Liu L, Strathdee SA, Garfein R. Factors associated with patterns of mobile technology use among persons who inject drugs. Subst Abus. 2016 Oct-Dec; 37(4):606-612. PMID: 27092425.
      View in: PubMed
    22. Story A, Garfein R, Hayward A, Rusovich V, Dadu A, Soltan V, Oprunenco A, Collins K, Sarin R, Quraishi S, Sharma M, Migliori GB, Varadarajan M, Falzon D. Monitoring Therapy Compliance of Tuberculosis Patients by using Video-Enabled Electronic Devices. Emerg Infect Dis. 2016 Mar; 22(3):538-40. PMID: 26891363; PMCID: PMC4766903.
    23. Seifert M, Georghiou SB, Catanzaro D, Rodrigues C, Crudu V, Victor TC, Garfein R, Catanzaro A, Rodwell TC. MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):912-8. PMID: 26763971; PMCID: PMC4809938 [Available on 10/01/16].
    24. Armenta RF, Roth AM, Wagner KD, Strathdee SA, Brodine SK, Cuevas-Mota J, Munoz FA, Garfein R. Prevalence and Correlates of the Use of Prefilled Syringes Among Persons Who Inject Drugs in San Diego, CA. J Urban Health. 2015 Dec; 92(6):1081-91. PMID: 26382653; PMCID: PMC4675744 [Available on 12/01/16].
    25. Catanzaro A, Rodwell TC, Catanzaro DG, Garfein R, Jackson RL, Seifert M, Georghiou SB, Trollip A, Groessl E, Hillery N, Crudu V, Victor TC, Rodrigues C, Lin GS, Valafar F, Desmond E, Eisenach K. Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. PLoS One. 2015; 10(8):e0136861. PMID: 26322781; PMCID: PMC4556461.
    26. Mehta SR, Wertheim JO, Brouwer KC, Wagner KD, Chaillon A, Strathdee S, Patterson TL, Rangel MG, Vargas M, Murrell B, Garfein R, Little SJ, Smith DM. HIV Transmission Networks in the San Diego-Tijuana Border Region. EBioMedicine. 2015 Oct; 2(10):1456-63. PMID: 26629540; PMCID: PMC4634195.
    27. Siddiqui SS, Armenta RF, Evans JL, Yu M, Cuevas-Mota J, Page K, Davidson P, Garfein R. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. Int J Drug Policy. 2015 Nov; 26(11):1150-7. PMID: 26252980; PMCID: PMC4581911 [Available on 11/01/16].
    28. Wagner KD, Liu L, Davidson PJ, Cuevas-Mota J, Armenta RF, Garfein R. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention. Drug Alcohol Depend. 2015 Aug 01; 153:215-20. PMID: 26091751; PMCID: PMC4512661.
    29. Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein R, Kamili S, Teshale EH. Hepatitis A and B among young persons who inject drugs--vaccination, past, and present infection. Vaccine. 2015 Jun 04; 33(24):2808-12. PMID: 25889161.
      View in: PubMed
    30. Muñoz FA, Servin AE, Garfein R, Ojeda VD, Rangel G, Zúñiga ML. Deportation history among HIV-positive Latinos in two US-Mexico border communities. J Immigr Minor Health. 2015 Feb; 17(1):104-11. PMID: 24136247; PMCID: PMC3991765.
    31. Collier MG, Bhaurla SK, Cuevas-Mota J, Armenta RF, Teshale EH, Garfein R. Awareness of HCV infection among persons who inject drugs in San Diego, California. Am J Public Health. 2015 Feb; 105(2):302-3. PMID: 25521877.
      View in: PubMed
    32. Armenta RF, Abramovitz D, Lozada R, Vera A, Garfein R, Magis-Rodríguez C, Strathdee SA. Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico. Salud Publica Mex. 2015; 57 Suppl 2:s107-12. PMID: 26545125.
      View in: PubMed
    33. Muñoz F, Burgos JL, Cuevas-Mota J, Teshale E, Garfein R. Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS Behav. 2015 Jan; 19(1):199-210. PMID: 24920342; PMCID: PMC4265001.
    34. Roth AM, Hensel DJ, Fortenberry JD, Garfein R, Gunn JK, Wiehe SE. Feasibility and acceptability of cell phone diaries to measure HIV risk behavior among female sex workers. AIDS Behav. 2014 Dec; 18(12):2314-24. PMID: 24643312; PMCID: PMC4356500.
    35. Hillery N, Groessl EJ, Trollip A, Catanzaro D, Jackson L, Rodwell TC, Garfein R, Lin SY, Eisenach K, Ganiats TG, Park D, Valafar F, Rodrigues C, Crudu V, Victor TC, Catanzaro A. The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis. Trials. 2014 Nov 06; 15:434. PMID: 25377177; PMCID: PMC4232628.
    36. Ajbani K, Lin SY, Rodrigues C, Nguyen D, Arroyo F, Kaping J, Jackson L, Garfein R, Catanzaro D, Eisenach K, Victor TC, Crudu V, Gler MT, Ismail N, Desmond E, Catanzaro A, Rodwell TC. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries. Antimicrob Agents Chemother. 2015 Jan; 59(1):414-20. PMID: 25367911; PMCID: PMC4291380.
    37. Roth AM, Armenta RA, Wagner KD, Roesch SC, Bluthenthal RN, Cuevas-Mota J, Garfein R. Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis. Subst Use Misuse. 2015 Jan; 50(2):205-14. PMID: 25313832; PMCID: PMC4356115.
    38. Wagner KD, Armenta RF, Roth AM, Maxwell JC, Cuevas-Mota J, Garfein R. Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug Alcohol Depend. 2014 Aug 01; 141:99-106. PMID: 24916748; PMCID: PMC4114932.
    39. Lindsay RP, Shin SS, Garfein R, Rusch ML, Novotny TE. The Association between active and passive smoking and latent tuberculosis infection in adults and children in the united states: results from NHANES. PLoS One. 2014; 9(3):e93137. PMID: 24664240; PMCID: PMC3963991.
    40. Mackesy-Amiti ME, Ouellet LJ, Finnegan L, Hagan H, Golub E, Latka M, Wagner K, Garfein R. Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention. AIDS Behav. 2014 Mar; 18(3):464-72. PMID: 23975477; PMCID: PMC3932146.
    41. Robertson AM, Garfein R, Wagner KD, Mehta SR, Magis-Rodriguez C, Cuevas-Mota J, Moreno-Zuniga PG, Strathdee SA. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda. Harm Reduct J. 2014 Feb 12; 11:4. PMID: 24520885; PMCID: PMC3944401.
    42. Rodwell TC, Valafar F, Douglas J, Qian L, Garfein R, Chawla A, Torres J, Zadorozhny V, Kim MS, Hoshide M, Catanzaro D, Jackson L, Lin G, Desmond E, Rodrigues C, Eisenach K, Victor TC, Ismail N, Crudu V, Gler MT, Catanzaro A. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol. 2014 Mar; 52(3):781-9. PMID: 24353002; PMCID: PMC3957771.
    43. Mahajan R, Collier MG, Kamili S, Drobeniuc J, Cuevas-Mota J, Garfein R, Teshale E. Hepatitis E virus among persons who inject drugs, San Diego, California, USA, 2009-2010. Emerg Infect Dis. 2013 Oct; 19(10):1664-6. PMID: 24047923; PMCID: PMC3810760.
    44. Shin SS, Moreno PG, Rao S, Garfein R, Novotny TE, Strathdee SA. Cigarette smoking and quit attempts among injection drug users in Tijuana, Mexico. Nicotine Tob Res. 2013 Dec; 15(12):2060-8. PMID: 23873979; PMCID: PMC3819980.
    45. Mackesy-Amiti ME, Finnegan L, Ouellet LJ, Golub ET, Hagan H, Hudson SM, Latka MH, Garfein R. Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study. AIDS Behav. 2013 Jul; 17(6):2075-83. PMID: 23142857; PMCID: PMC3672505.
    46. Garfein R, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA. J Urban Health. 2013 Jun; 90(3):516-28. PMID: 22766605; PMCID: PMC3665980.
    47. Bojorquez I, Barnes RF, Flood J, López-Gatell H, Garfein R, Bäcker CE, Alpuche C, Vinetz JM, Catanzaro A, Kato-Maeda M, Rodwell TC. Multidrug-resistant tuberculosis among patients in Baja California, Mexico, and Hispanic patients in California. Am J Public Health. 2013 Jul; 103(7):1301-5. PMID: 23678924; PMCID: PMC3682598.
    48. Goodman D, Fraga MA, Brodine S, Ibarra MD, Garfein R. Prevalence of diabetes and metabolic syndrome in a migrant Mixtec population, Baja California, Mexico. J Immigr Minor Health. 2013 Feb; 15(1):93-100. PMID: 22961334; PMCID: PMC4727828.
    49. Grenfell P, Baptista Leite R, Garfein R, de Lussigny S, Platt L, Rhodes T. Tuberculosis, injecting drug use and integrated HIV-TB care: a review of the literature. Drug Alcohol Depend. 2013 May 01; 129(3):180-209. PMID: 23306095.
      View in: PubMed
    50. Shin SS, Gallardo M, Lozada R, Abramovitz D, Burgos JL, Laniado-Laborin R, Rodwell TC, Novotny TE, Strathdee SA, Garfein R. Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study. Pulm Med. 2012; 2012:828106. PMID: 23304497; PMCID: PMC3529865.
    51. Volkmann T, Fraga MA, Brodine SK, Iñiguez-Stevens E, Cepeda A, Elder JP, Garfein R. Drug-scene familiarity and exposure to gang violence among residents in a rural farming community in Baja California, Mexico. Glob Public Health. 2013; 8(1):65-78. PMID: 23072623; PMCID: PMC3549003.
    52. Yen YF, Rodwell TC, Yen MY, Hsu YH, Chuang P, Li LH, Su LW, Yang YH, Jiang XR, Fang YC, Garfein R. HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010. Am J Drug Alcohol Abuse. 2012 Nov; 38(6):544-50. PMID: 22783806; PMCID: PMC4229362.
    53. Velasquez MG, Laniado-Laborin R, Rodwell TC, Cerecer P, Lozada R, Cuevas-Mota J, Burgos JL, Garfein R. Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico. Rev Panam Salud Publica. 2012 Jul; 32(1):30-5. PMID: 22910722; PMCID: PMC3711229.
    54. Volkmann T, Shin SS, Garfein R, Patterson TL, Pollini RA, Wagner KD, Artamanova I, Strathdee SA. Border crossing to inject drugs in Mexico among injection drug users in San Diego, California. J Immigr Minor Health. 2012 Apr; 14(2):281-6. PMID: 21442300; PMCID: PMC3163238.
    55. Georghiou SB, Magana M, Garfein R, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One. 2012; 7(3):e33275. PMID: 22479378; PMCID: PMC3315572.
    56. Baird SJ, Garfein R, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012 Apr 07; 379(9823):1320-9. PMID: 22341825.
      View in: PubMed
    57. Wagner KD, Moynihan MJ, Strathdee SA, Cuevas-Mota J, Clark M, Zúñiga ML, Volkmann TA, Teshale E, Garfein R. The social and environmental context of cross-border drug use in Mexico: findings from a mixed methods study of young injection drug users living in San Diego, CA. J Ethn Subst Abuse. 2012; 11(4):362-78. PMID: 23216441; PMCID: PMC3531810.
    58. Ghanem A, Little SJ, Drumright L, Liu L, Morris S, Garfein R. High-risk behaviors associated with injection drug use among recently HIV-infected men who have sex with men in San Diego, CA. AIDS Behav. 2011 Oct; 15(7):1561-9. PMID: 21607643; PMCID: PMC4394837.
    59. Garfein R, Burgos JL, Rodriquez-Lainz A, Brodine S, Pietrucha A, Rondinelli A, Laniado-Laborin R, Ibarra E, Cañez A, Fraga M. Latent tuberculosis infection in a migrant agricultural community in Baja California, Mexico. J Immigr Minor Health. 2011 Oct; 13(5):940-7. PMID: 20669048.
      View in: PubMed
    60. Pollini RA, Banta-Green CJ, Cuevas-Mota J, Metzner M, Teshale E, Garfein R. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil. 2011 Oct; 2(1):173-180. PMID: 23293547.
      View in: PubMed
    61. Smith BD, Drobeniuc J, Jewett A, Branson BM, Garfein R, Teshale E, Kamili S, Weinbaum CM. Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. J Infect Dis. 2011 Sep 15; 204(6):825-31. PMID: 21849279.
      View in: PubMed
    62. Barnes RF, Moore ML, Garfein R, Brodine S, Strathdee SA, Rodwell TC. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Ann Epidemiol. 2011 Oct; 21(10):791-5. PMID: 21820320; PMCID: PMC3166369.
    63. Deiss RG, Lozada RM, Burgos JL, Strathdee SA, Gallardo M, Cuevas J, Garfein R. HIV prevalence and sexual risk behaviour among non-injection drug users in Tijuana, Mexico. Glob Public Health. 2012; 7(2):175-83. PMID: 21390967; PMCID: PMC3163240.
    64. Mackesy-Amiti ME, Ouellet LJ, Golub ET, Hudson S, Hagan H, Garfein R. Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial. Addiction. 2011 Mar; 106(3):601-8. PMID: 21182555.
      View in: PubMed
    65. Drumright LN, Hagan H, Thomas DL, Latka MH, Golub ET, Garfein R, Clapp JD, Campbell JV, Bonner S, Kapadia F, Thiel TK, Strathdee SA. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol. 2011 Jul; 55(1):45-52. PMID: 21145862; PMCID: PMC3094600.
    66. Riley ED, Kral AH, Stopka TJ, Garfein R, Reuckhaus P, Bluthenthal RN. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users. J Urban Health. 2010 Jul; 87(4):534-42. PMID: 20526690; PMCID: PMC2900569.
    67. Kral AH, Garfein R. Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California. J Urban Health. 2010 Jul; 87(4):531-3. PMID: 20549567; PMCID: PMC2900576.
    68. Cooper EN, Dodson C, Stopka TJ, Riley ED, Garfein R, Bluthenthal RN. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health. 2010 Jul; 87(4):543-52. PMID: 20549568; PMCID: PMC2900565.
    69. Garfein R, Stopka TJ, Pavlinac PB, Ross A, Haye BK, Riley ED, Bluthenthal RN. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010 Jul; 87(4):576-85. PMID: 20535641; PMCID: PMC2900579.
    70. Morris SR, Little SJ, Cunningham T, Garfein R, Richman DD, Smith DM. Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med. 2010 Jun 15; 152(12):778-85. PMID: 20547906; PMCID: PMC2922925.
    71. Garfein R, Metzner M, Cuevas J, Bousman CA, Patterson T. Formative Assessment of ARM-U: A Modular Intervention for Decreasing Risk Behaviors Among HIV-Positive and HIV-Negative Methamphetamine-Using MSM. Open AIDS J. 2010 May 14; 4:105-15. PMID: 20657829; PMCID: PMC2905777.
    72. Garfein R, Laniado-Laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, Cuevas-Mota J, Cerecer P, Moser K, Volker ML, Strathdee SA. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis. 2010 May; 16(5):757-63. PMID: 20409363.
      View in: PubMed
    73. Rodwell TC, Kapasi AJ, Moore M, Milian-Suazo F, Harris B, Guerrero LP, Moser K, Strathdee SA, Garfein R. Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Int J Infect Dis. 2010 Sep; 14 Suppl 3:e129-35. PMID: 20399697; PMCID: PMC2920372.
    74. Cheng WS, Garfein R, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs. 2010 Mar; 42(1):11-8. PMID: 20464802; PMCID: PMC2907747.
    75. Semaan S, Heckathorn DD, Des Jarlais DC, Garfein R. Ethical considerations in surveys employing respondent-driven sampling. Am J Public Health. 2010 Apr; 100(4):582-3; author reply 583-4. PMID: 20167881; PMCID: PMC2836345.
    76. Rodwell TC, Barnes RF, Moore M, Strathdee SA, Raich A, Moser KS, Garfein R. HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden. Am J Public Health. 2010 Apr 01; 100 Suppl 1:S178-85. PMID: 20147681; PMCID: PMC2837460.
    77. Cheng WS, Garfein R, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego. Subst Use Misuse. 2010; 45(1-2):116-33. PMID: 20025442; PMCID: PMC2861916.
    78. Rondinelli AJ, Ouellet LJ, Strathdee SA, Latka MH, Hudson SM, Hagan H, Garfein R. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend. 2009 Sep 01; 104(1-2):167-74. PMID: 19559543.
      View in: PubMed
    79. Deiss R, Garfein R, Lozada R, Burgos JL, Brouwer KC, Moser KS, Zuniga ML, Rodwell TC, Ojeda VD, Strathdee SA. Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health. 2009 Aug; 99(8):1491-5. PMID: 19542040.
      View in: PubMed
    80. Holtzman D, Barry V, Ouellet LJ, Des Jarlais DC, Vlahov D, Golub ET, Hudson SM, Garfein R. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med. 2009 Aug; 49(1):68-73. PMID: 19410600.
      View in: PubMed
    81. Volkow P, Brouwer KC, Loza O, Ramos R, Lozada R, Garfein R, Magis-Rodriguez C, Firestone-Cruz M, Strathdee SA. Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy. 2009 Sep; 20(5):409-12. PMID: 19230645; PMCID: PMC2955515.
    82. Deiss RG, Rodwell TC, Garfein R. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009 Jan 01; 48(1):72-82. PMID: 19046064; PMCID: PMC3110742.
    83. Cheng WS, Garfein R, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Differences in sexual risk behaviors among male and female HIV-seronegative heterosexual methamphetamine users. Am J Drug Alcohol Abuse. 2009; 35(5):295-300. PMID: 19591066; PMCID: PMC2913870.
    84. Amon JJ, Garfein R, Ahdieh-Grant L, Armstrong GL, Ouellet LJ, Latka MH, Vlahov D, Strathdee SA, Hudson SM, Kerndt P, Des Jarlais D, Williams IT. Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. Clin Infect Dis. 2008 Jun 15; 46(12):1852-8. PMID: 18462109.
      View in: PubMed
    85. Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein R, Pu M, Thomas DL, Thiel TK, Strathdee SA. A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. Am J Public Health. 2008 May; 98(5):853-61. PMID: 18382005; PMCID: PMC2374802.
    86. Semaan S, Santibanez S, Garfein R, Heckathorn DD, Des Jarlais DC. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy. 2009 Jan; 20(1):14-27. PMID: 18243679.
      View in: PubMed
    87. Vlahov D, Wang C, Ompad D, Fuller CM, Caceres W, Ouellet L, Kerndt P, Jarlais DC, Garfein R. Mortality risk among recent-onset injection drug users in five U.S. cities. Subst Use Misuse. 2008; 43(3-4):413-28. PMID: 18365941.
      View in: PubMed
    88. Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, Garfein R. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009 Apr; 13(2):217-24. PMID: 17876699; PMCID: PMC3690571.
    89. Garfein R, Golub ET, Greenberg AE, Hagan H, Hanson DL, Hudson SM, Kapadia F, Latka MH, Ouellet LJ, Purcell DW, Strathdee SA, Thiede H. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS. 2007 Sep 12; 21(14):1923-32. PMID: 17721100.
      View in: PubMed
    90. Garfein R, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, Strathdee SA, Williams IT, Bailey SL, Hagan H, Golub ET, Kerndt P, Hanson DL, Latka MH. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S4-17. PMID: 17582705.
      View in: PubMed
    91. Coady MH, Latka MH, Thiede H, Golub ET, Ouellet L, Hudson SM, Kapadia F, Garfein R. Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav. 2007 Nov; 11(6):854-63. PMID: 17551825.
      View in: PubMed
    92. White EF, Garfein R, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Pérez SG, Magis-Rodríguez C, Conde-Glez CJ, Strathdee SA. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex. 2007 May-Jun; 49(3):165-72. PMID: 17589770; PMCID: PMC2743977.
    93. Burt RD, Hagan H, Garfein R, Sabin K, Weinbaum C, Thiede H. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health. 2007 May; 84(3):436-54. PMID: 17356901; PMCID: PMC2231834.
    94. Purcell DW, Garfein R, Latka MH, Thiede H, Hudson S, Bonner S, Golub ET, Ouellet LJ. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S73-80. PMID: 17466465.
      View in: PubMed
    95. Thiede H, Hagan H, Campbell JV, Strathdee SA, Bailey SL, Hudson SM, Kapadia F, Garfein R. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S39-47. PMID: 17466464.
      View in: PubMed
    96. Bailey SL, Ouellet LJ, Mackesy-Amiti ME, Golub ET, Hagan H, Hudson SM, Latka MH, Gao W, Garfein R. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S18-29. PMID: 17434267.
      View in: PubMed
    97. Golub ET, Strathdee SA, Bailey SL, Hagan H, Latka MH, Hudson SM, Garfein R. Distributive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S30-8. PMID: 17398039.
      View in: PubMed
    98. Hagan H, Campbell JV, Thiede H, Strathdee SA, Ouellet L, Latka M, Hudson S, Garfein R. Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S48-55. PMID: 17363193; PMCID: PMC2128771.
    99. Campbell JV, Garfein R, Thiede H, Hagan H, Ouellet LJ, Golub ET, Hudson SM, Ompad DC, Weinbaum C. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 2007 Nov; 91 Suppl 1:S64-72. PMID: 17276018.
      View in: PubMed
    100. Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein R, Lin LS, Sullivan PS. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007; 122 Suppl 1:48-55. PMID: 17354527; PMCID: PMC1804107.
    101. Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein R, Thomas DL, Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). J Urban Health. 2007 Jan; 84(1):99-115. PMID: 17200799; PMCID: PMC2078252.
    102. Stopka TJ, Garfein R, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007 Jan; 84(1):116-25. PMID: 17151941; PMCID: PMC2078247.
    103. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein R. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006 Nov-Dec; 121(6):710-9. PMID: 17278406; PMCID: PMC1781913.
    104. Purcell DW, Mizuno Y, Metsch LR, Garfein R, Tobin K, Knight K, Latka MH. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006 Jul; 83(4):656-68. PMID: 16736116; PMCID: PMC2430482.
    105. Hagan H, Latka MH, Campbell JV, Golub ET, Garfein R, Thomas DA, Kapadia F, Strathdee SA. Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities. Clin Infect Dis. 2006 Mar 01; 42(5):669-72. PMID: 16447112.
      View in: PubMed
    106. Santibanez SS, Garfein R, Swartzendruber A, Purcell DW, Paxton LA, Greenberg AE. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health. 2006 Jan; 83(1):86-100. PMID: 16736357; PMCID: PMC2258331.
    107. Campbell JV, Hagan H, Latka MH, Garfein R, Golub ET, Coady MH, Thomas DL, Strathdee SA. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend. 2006 Feb 28; 81(3):259-65. PMID: 16129567; PMCID: PMC2196223.
    108. Plitt SS, Garfein R, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis. 2005 Jul; 32(7):446-53. PMID: 15976603.
      View in: PubMed
    109. Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, Kerndt P, Maslow C, Wu Y, Vlahov D, Garfein R, Strathdee SA. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health. 2005 Apr; 95(4):703-9. PMID: 15798133; PMCID: PMC1449244.
    110. Santibanez SS, Garfein R, Swartzendruber A, Kerndt PR, Morse E, Ompad D, Strathdee S, Williams IT, Friedman SR, Ouellet LJ. Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug Alcohol Depend. 2005 Mar 07; 77(3):227-33. PMID: 15734222.
      View in: PubMed
    111. Huo D, Bailey SL, Garfein R, Ouellet LJ. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996. Subst Use Misuse. 2005; 40(1):63-76. PMID: 15702649.
      View in: PubMed
    112. Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein R. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. J Clin Virol. 2004 Nov; 31(3):210-4. PMID: 15465414.
      View in: PubMed
    113. Garfein R, Bower WA, Loney CM, Hutin YJ, Xia GL, Jawanda J, Groom AV, Nainan OV, Murphy JS, Bell BP. Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology. 2004 Oct; 40(4):865-73. PMID: 15382123.
      View in: PubMed
    114. Havens JR, Strathdee SA, Fuller CM, Ikeda R, Friedman SR, Des Jarlais DC, Morse PS, Bailey S, Kerndt P, Garfein R. Correlates of attempted suicide among young injection drug users in a multi-site cohort. Drug Alcohol Depend. 2004 Sep 06; 75(3):261-9. PMID: 15283947.
      View in: PubMed
    115. Becker Buxton M, Vlahov D, Strathdee SA, Des Jarlais DC, Morse EV, Ouellet L, Kerndt P, Garfein R. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004 Aug 16; 75(2):177-83. PMID: 15276223.
      View in: PubMed
    116. Golub ET, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein R, Thomas DL, Strathdee SA. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health. 2004 Jun; 81(2):278-90. PMID: 15136661; PMCID: PMC3456451.
    117. Garfein R, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, Kerndt PR, Word C, Fernando MD, Ouellet LJ, Holmberg SD. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health. 2004 Jun; 81(2):260-7. PMID: 15136659; PMCID: PMC3456450.
    118. Bailey SL, Huo D, Garfein R, Ouellet LJ. The use of needle exchange by young injection drug users. J Acquir Immune Defic Syndr. 2003 Sep 01; 34(1):67-70. PMID: 14501796.
      View in: PubMed
    119. Friedman SR, Ompad DC, Maslow C, Young R, Case P, Hudson SM, Diaz T, Morse E, Bailey S, Des Jarlais DC, Perlis T, Hollibaugh A, Garfein R. HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women. Am J Public Health. 2003 Jun; 93(6):902-6. PMID: 12773350; PMCID: PMC1447865.
    120. Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, Rockwell R, Edwards V, Friedman SR, Monterroso E, Williams I, Garfein R. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003 Mar 01; 157(5):467-71. PMID: 12615611.
      View in: PubMed
    121. Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, Morse E EV, Williams I, Garfein R. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology. 2002 Nov; 13(6):738-41. PMID: 12410020.
      View in: PubMed
    122. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein R. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002 Apr 01; 155(7):645-53. PMID: 11914192.
      View in: PubMed
    123. Cody SH, Nainan OV, Garfein R, Meyers H, Bell BP, Shapiro CN, Meeks EL, Pitt H, Mouzin E, Alter MJ, Margolis HS, Vugia DJ. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med. 2002 Feb 11; 162(3):345-50. PMID: 11822928.
      View in: PubMed